API |
| |
Name |
Specification |
Appearance |
CAS |
|
1 |
Lapatinib ditosylate |
99% |
light yellow crystalline powder |
388083-78-8 |
2 |
Sorafenib tosylate |
99% |
off-white powder |
475207-59-1 |
3 |
Erlotinib hydrochloride |
99% |
off-white powder |
183319-69-9 |
4 |
Imatinib mesylate |
99% |
light yellow to white crystalline powder |
220127-57-1 |
Anticancer |
5 |
Anastrozole |
99% |
off-white crystalline powder |
120511-73-1 |
6 |
letrozole |
99% |
off-white crystalline powder |
112809-51-5 |
7 |
Fulvstrant |
99% |
white powder |
129453-61-8 |
Anti-osteoporotic |
8 |
Ibandronate sodium |
99% |
white crystalline powder |
138926-19-9 |
Antemetic |
9 |
Palonosetron hydrochloride |
99% |
off-white crystalline powder |
135729-62-3 |
Others |
10 |
Entecavir hydrate |
99% |
white crystalline powder |
209216-23-9 |
11 |
Rocuronium bromide |
99% |
light yellow crystalline powder |
119302-91-9 |
12 |
Memantine hydrochloride |
99% |
white crystalline powder |
41100-52-1 |
13 |
Ceftiofur sodium |
86% |
light yellow to white powder |
104010-37-9 |
14 |
Ceftiofur hydrochloride |
98% |
off-white powder |
103980-44-5 |
15 |
VERALIPRIDE |
99% |
White crystalline powder |
66644-81-3 |
Intermediates |
| |
Name |
Specification |
Appearance |
CAS |
Lapatinib Intermediate |
1 |
2-(Methylsulfonyl)Ethylamine HCl |
99% |
light yellow crystalline powder |
104458-24-4 |
2 |
N-[3-chloro-4-(3-fluorobenzyloxy)-phenyl]-6-iodoquinazolin-4-amine |
99% |
light yellow crystalline powder |
231278-20-9 |
Ibandronate sodium Intermediate |
3 |
3-(N-Methylpentylamino)propionic acid hydrochloride |
99% |
white crystalline powder |
625120-81-2 |
Anastrozole Intermediate |
4 |
3,5-Bis(2-cyanoprop-2-yl)toluene |
99% |
white crystalline powder |
120511-72-0 |
5 |
5-Methyl-1,3-benzenediacetonitrile |
99% |
off-white crystalline powder |
120511-74-2 |
Palonosetron hydrochloride Intermediate |
6 |
(S)-3-Aminoquinuclidine dihydrochloride |
99% |
off-white crystalline powder |
119904-90-4 |
7 |
5,6,7,8-tetrahydro-1-naphthalenecarboxylic acid |
99% |
white crystalline powder |
4242-18-6 |
Intermediate of Fulvstrant |
8 |
Estra-1,3,5(10)-triene-3,17-diol,7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]-,(7a,17b)- |
|
|
153004-31-0 |
9 |
Estra-1,3,5(10)-triene-3,17-diol,7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]-,17-acetate,(7a,17b)- |
|
|
875573-69-6 |
10 |
Estra-1,3,5(10)-triene-3,17-diol,7-(9-bromononyl)-,17-acetate,(7a,17b)- |
|
|
875573-66-3 |
Erlotinib Intermediate |
11 |
6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone |
99% |
white to yellow powder |
179688-29-0 |
12 |
3-Aminophenylacetylene |
99% |
colorless or light yellow liquid |
54060-30-9 |
13 |
4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline |
99% |
white to yellow powder |
183322-18-1 |
14 |
(2b,3a,5a,16b,17b)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol |
99% |
white crystalline powder |
119302-20-4 |
15 |
(2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane |
99% |
white crystalline powder |
119302-24-8 |
Telmisartan Intermediate |
16 |
Double Benzimidazole |
99% |
White to off-white powder |
152628-02-9 |
